Cardiovascular risk scores help predict a person’s chance of heart disease, stroke, or related events, guiding prevention and treatment. Tools like QRISK, Framingham, ASCVD, and CHA₂DS₂-VASc use ...

Panel (A) shows classifications based on the ASCVD Risk Estimator Plus, where 45% (209/465) of patients would not have qualified for statin therapy or further testing. Panel (B) displays results from ...

The 2013 American College of Cardiology/American Heart Association (ACC/AHA) guidelines for the management of blood cholesterol represent a shift in the treatment approach for the primary prevention ...

Use of tirzepatide, compared with dulaglutide, is associated with a 20% lower risk for MACE among patients with T2D and ASCVD.

Please provide your email address to receive an email when new articles are posted on . BMI reduction below 25 kg/m 2 with tirzepatide was linked to improved 10-year ASCVD risk. Lower BMI was also ...

Women with uterine fibroids, compared with those without the benign gynecological tumors, have a greater risk of developing atherosclerotic cardiovascular disease (ASCVD) up to 10 years down the line, ...

Current cardiac screening tools used to prevent heart attacks fail to identify nearly half of the people who are actually at risk of having one, according to a new study led by Mount Sinai researchers ...